|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Nordion International, Manufacturer of TheraSphere®, to Host Educational Symposium at the 2013 Gastrointestinal Cancers Symposium
1/24/2013 6:28:52 AM
Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced today it is hosting an educational symposium titled “The Expanding Role of Radioembolization for the Treatment of Hepatocellular Carcinoma (HCC): Latest Information about Radioembolization, Yttrium-90 (Y-90) Glass Microspheres in HCC and an Update on Phase III Clinical Trials.” The symposium, designed to educate referring physicians, including Medical Oncologists, Hepatologists and Gastroenterologists, is being held at this year’s 2013 Gastrointestinal Cancers Symposium in San Francisco from January 24 – 26, 2013.
|
|
|
|
|
|
|
|
|
|
|